Document:

Registration Rights Agreement

 Exhibit 4.3 
 Execution Version 
 REGISTRATION RIGHTS AGREEMENT 

by and among 
 GMX RESOURCES INC. 
 and 

the Committed Holders Listed on the Signature Page hereto 
 Relating to Shares of Common Stock 
 Dated as of December 7, 2012

 REGISTRATION RIGHTS AGREEMENT 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 7, 2012, by and among
GMX Resources Inc., a Delaware corporation (the “Company”) and the Committed Holders (as defined below) set forth on the signature pages hereto for the benefit of certain Holders, each of whom has agreed to purchase (i) the
Company’s Senior Secured Notes Series B due 2017 (collectively, the “Notes”) and (ii) an aggregate 15,979,253 shares of the Company’s common stock, par value $0.001 per share (such shares of the Company’s common
stock, or any other capital stock of the Company into which such common stock is reclassified, reconstituted, exchanged, or converted, the “Securities”) pursuant to the Commitment Agreements (as defined below) and the Purchase
Agreements (as defined below). The Company has issued the Securities to the Investors pursuant to the Commitment Agreements and the Purchase Agreements. 
 This Agreement is made pursuant to (i) the Commitment Agreements, dated November 7, 2012, by and between the Company and each Committed Holder named therein (the “Commitment
Agreements”), and (ii) the Securities Purchase Agreements, dated as of December 7, 2012, by and between the Company, the Guarantors named therein and the Committed Holders named therein (the “Purchase
Agreements”). In order to induce the Committed Holders to purchase the Notes and the Securities, the Company has agreed to provide the registration rights set forth in this Agreement. 

The parties hereby agree as follows: 
 SECTION 1. Definitions. As used in this Agreement, the following capitalized terms shall have the following meanings: 
 Affiliate: An “affiliate” of the Company, as defined in Rule 144 of the Securities Act. 
 Business Day: Any day other than a Saturday, Sunday or U.S. federal holiday or a day on which banking institutions or trust companies located in New York, New York are authorized or obligated by
law or executive order to be closed. 
 Closing Date: The date of this Agreement. 

Commission: The Securities and Exchange Commission. 
 Committed Holders: The Holders who entered into a Commitment Agreement and a Purchase Agreement. 
 Commitment Agreements: As defined in the preamble hereto. 

Effectiveness Date: As defined in Section 3(a) hereto. 

Effectiveness Period: As defined in Section 3(a) hereto. 

Effectiveness Target Date: As defined in Section 3(a) hereto. 

  
 1 

 Exchange Act: The Securities Exchange Act of 1934, as amended. 

Holders: As defined in Section 2(b) hereto. 
 Indemnified Holder: As defined in Section 7(a) hereto. 
 Initial
Issuance: The issuance and sale by the Company of the Securities to the Committed Holders pursuant to the Commitment Agreements and the Purchase Agreements. 
 Issuer Free Writing Prospectus: As defined in Section 3(c) hereof. 

Late Payments: As defined in Section 4 hereof. 
 Notes: As defined in the preamble hereto. 
 Notice and
Questionnaire: A written notice substantially in the form of Annex A attached hereto, containing such information as the Company may reasonably request, executed by the respective Committed Holder and delivered to the Company on such date
as the Company shall reasonably request prior to its use in a Shelf Registration Statement or Prospectus. 
 Notice
Holder: On any date, any Holder of Transfer Restricted Securities that has delivered a Notice and Questionnaire to the Company on or prior to such date. 
 Person: An individual, partnership, limited partnership, limited liability company, corporation, trust or unincorporated organization, or a government or agency or political subdivision thereof.

 Prospectus: The prospectus included in a Shelf Registration Statement, as amended or supplemented by any prospectus
supplement and by all other amendments thereto, including post-effective amendments, and all material incorporated by reference into such Prospectus. 
 Purchase Agreements: As defined in the preamble hereto 
 Registration
Default: As defined in Section 4 hereof. 
 Registration Target Date: March 6, 2013. 

Rule 144: Rule 144 as promulgated under the Securities Act. 

Securities: As defined in the preamble hereto. 
 Securities Act: The Securities Act of 1933, as amended. 
 Shelf
Registration Statement: As defined in Section 3(a)(i) hereof. 
 Transfer Restricted Securities: Each Security,
until the earliest to occur of (a) the date on which such Security has been effectively registered for resale under the Securities Act and disposed of in accordance with a Shelf Registration Statement, (b) the date on which such

  
 2 

 
Security ceases to be outstanding (whether as a result of redemption, repurchase and cancellation, conversion or otherwise), or (c) the date on which such Securities are eligible to be sold
by the Holder thereof pursuant to Rule 144 in a single transaction without limitation and without restriction. 
 Unless the
context otherwise requires, the singular includes the plural, and words in the plural include the singular. 
 SECTION 2.
Securities Subject to this Agreement. 
 (a) Transfer Restricted Securities. The securities entitled to the benefits of
this Agreement are the Transfer Restricted Securities. 
 (b) Holders of Transfer Restricted Securities. A Person is deemed to
be a holder of Transfer Restricted Securities (each, a “Holder”) whenever such Person owns Transfer Restricted Securities. 
 SECTION 3. Shelf Registration. 
 (a) The Company shall: 

(i) by the Registration Target Date, cause to be filed a shelf registration statement pursuant to Rule 415 under the
Securities Act (the “Shelf Registration Statement”), which Shelf Registration Statement shall provide for resales of all Transfer Restricted Securities held by Holders who have timely provided the information required pursuant to
Section 3(b) hereof; and 
 (ii) use its reasonable best efforts to cause the Shelf Registration Statement
to be declared effective by the Commission on or before the 120th day after the earlier of the date the Shelf Registration Statement is filed and the Registration Target Date (or if such 120th day is not a Business Day, the next succeeding Business
Day) (the “Effectiveness Target Date”, and the date of such effectiveness, the “Effectiveness Date”). 
 The Company shall use its reasonable best efforts to keep the Shelf Registration Statement continuously effective, supplemented and amended as required by the provisions of Sections 5(a) and
(b) hereof to the extent necessary to ensure that it is available for resales of Transfer Restricted Securities by the Holders of Transfer Restricted Securities entitled to the benefit of this Agreement, and to ensure that it conforms with the
requirements of this Agreement, the Securities Act and the policies, rules and regulations of the Commission as announced from time to time, until such time as all the Transfer Restricted Securities covered by such Shelf Registration Statement have
been resold pursuant to such Shelf Registration Statement (the “Effectiveness Period”); provided that the Company may, from time to time, for a period of up to an aggregate of 45 days in any calendar year determine that the Shelf
Registration Statement is not usable for a valid business purpose (a “Blackout Period”). 

  
 3 

 (b) No Holder of Transfer Restricted Securities may include any of its Transfer Restricted
Securities in any Shelf Registration Statement pursuant to this Agreement unless and until such Holder furnishes to the Company in writing, within 10 days after receipt of a request therefor, such information as the Company may reasonably request to
be included in the Notice and Questionnaire for use in connection with any Shelf Registration Statement or Prospectus or preliminary Prospectus included therein. Each Holder as to which any Shelf Registration Statement is being effected agrees to
furnish promptly to the Company any updates to the Notice and Questionnaire or additional information as the Company may reasonably request. 
 (c) Each Holder represents and agrees that, unless it obtains the prior written consent of the Company, it will not make any offer relating to the Securities that would constitute an “issuer free
writing prospectus,” as defined in Rule 433 (an “Issuer Free Writing Prospectus”), or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with the Commission. The
Company represents that any Issuer Free Writing Prospectus used by the Company, when taken together with the information in the Shelf Registration Statement and the Prospectus, will not include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
 (d) If the Shelf Registration Statement ceases to be effective for any reason at any time during the Effectiveness Period (except during a Blackout Period or other than because all Transfer Restricted
Securities registered thereunder shall have been resold pursuant thereto), the Company shall use its reasonable best efforts to obtain the prompt withdrawal of any order suspending effectiveness thereof or promptly file or designate a subsequent
Shelf Registration Statement covering all of the Securities that as of the date of such filing or designation are Transfer Restricted Securities. If such a subsequent Shelf Registration Statement is filed or designated (and is not already
effective), the Company shall use its reasonable best efforts to cause the subsequent Shelf Registration Statement to become effective as promptly as is practicable after such filing or designation and to keep such subsequent Shelf Registration
Statement continuously effective until the end of the Effectiveness Period. 
 (e) The Company shall supplement and amend the
Shelf Registration Statement during the Effectiveness Period as and if required by the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration Statement. 

(f) The Company shall cause the Shelf Registration Statement and the related Prospectus and any amendment or supplement thereto, as of
the effective date of the Shelf Registration Statement or such amendment or supplement, and any Issuer Free Writing Prospectus, as of the date thereof, (i) to comply in all material respects with the applicable requirements of the Securities
Act, and (ii) not to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein (in the case of the Prospectus and any Issuer Free Writing
Prospectus, in light of the circumstances under which they were made) not misleading. 
 (g) Each Holder agrees that if such
Holder wishes to sell Transfer Restricted Securities pursuant to a Shelf Registration Statement and related Prospectus, it will do so only in accordance with the terms and conditions of this Agreement. 

  
 4 

 SECTION 4. Late Payments. If (i) prior to or on the Registration Target
Date, the Shelf Registration Statement is not filed, or on file, with the Commission, (ii) the Shelf Registration Statement has not become effective by the Effectiveness Target Date, (iii) except during a Blackout Period, the Shelf
Registration Statement is filed and declared effective but sales cannot be made thereunder during the applicable Effectiveness Period for any reason (including any suspension of the use of a Shelf Registration Statement under Section 5(b)
hereof) (provided, however, that any Holder that has not timely provided the information required in Section 3(b) shall not be entitled to receive the Late Payments (as defined below) for a Registration Default under this
Section 4(iii)), or (iv) during the Effectiveness Period Blackout Periods exceed an aggregate of 45 days in any calendar year (each such event referred to in clauses (i) through (iv), a “Registration Default”), the
Company hereby agrees to pay to each Committed Holder an amount equal to $0.01444 per share of Transfer Restricted Securities owned by such Committed Holder and affected by such Registration Default (subject to adjustment for stock splits or similar
changes to the Transfer Restricted Securities) for each month of such Registration Default (the “Late Payments”). The Late Payments will be prorated on a daily basis for partial months and will be paid to the Committed Holders by
wire transfer or check within five Business Days after (A) in the case of clauses (i) and (ii) in the immediately preceding sentence, the earlier of (x) the last Business Day of each month following the Registration Target Date
or Effectiveness Target Date and (y) the Effectiveness Date, or (B) in the case of clauses (iii) and (iv) in the immediately preceding sentence, the last Business Day of each month following the date of the applicable
Registration Default. All accrued Late Payment obligations of the Company set forth herein that are outstanding with respect to any Transfer Restricted Security at the time such security ceases to be a Transfer Restricted Security shall survive
until all such obligations with respect to such security shall have been satisfied in full. 
 SECTION 5. Registration
Procedures. 
 (a) If required pursuant to Section 3 hereof, in connection with the Shelf Registration Statement, the
Company shall comply with all the provisions of Section 5(b) hereof and shall use its reasonable best efforts to effect such registration to permit the resale of the Transfer Restricted Securities being sold in accordance with the intended
method or methods of distribution thereof, and pursuant thereto the Company will prepare and file with the Commission a Shelf Registration Statement relating to the registration on any appropriate form under the Securities Act, which form shall be
available for the sale of the Transfer Restricted Securities in accordance with the intended method or methods of distribution thereof in accordance with the time periods set forth in Section 3. 

(b) General Provisions. In connection with the Shelf Registration Statement and any Prospectus required by this Agreement to
permit the sale or resale of Transfer Restricted Securities, the Company shall: 
 (i) except during a Blackout
Period or the existence of any fact or event of the kind described in Section 5(b)(iii)(D), use its reasonable best efforts to keep such Shelf Registration Statement continuously effective during the Effectiveness Period; upon the occurrence of
any event that would cause any such Shelf Registration Statement or the Prospectus contained therein (A) to contain a material misstatement or omission or (B) not to be effective and usable for resale of Transfer Restricted Securities
during the 

  
 5 

 
Effectiveness Period, the Company shall file promptly an appropriate amendment to such Shelf Registration Statement, a supplement to the related Prospectus or file any other required document, in
the case of clause (A), correcting any such misstatement or omission, and, in the case of either clause (A) or (B), use its reasonable best efforts to cause such amendment to be declared effective and such Shelf Registration Statement and the
related Prospectus to become usable for their intended purpose(s) as soon as practicable thereafter; 
 (ii)
except during a Blackout Period, prepare and file with the Commission such amendments and post-effective amendments to the Shelf Registration Statement as may be necessary to keep the Shelf Registration Statement effective during the Effectiveness
Period; cause the Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities Act, and to comply fully with the applicable provisions of Rules 424 and 430A under
the Securities Act in a timely manner; and comply with the provisions of the Securities Act to enable the disposition of all Transfer Restricted Securities covered by the Shelf Registration Statement during the Effectiveness Period in accordance
with the intended method or methods of distribution by the sellers thereof set forth or to be set forth in the Shelf Registration Statement or supplement to the Prospectus; 

(iii) advise the Holders whose Transfer Restricted Securities are included in the Shelf Registration Statement promptly
and, if requested by such Persons, to confirm such advice in writing, (A) when the Prospectus or any Prospectus supplement or post effective amendment has been filed, and, with respect to the Shelf Registration Statement or any post-effective
amendment thereto, when the same has become effective, (B) of any request by the Commission for amendments to the Shelf Registration Statement or amendments or supplements to the Prospectus or for additional information relating thereto,
(C) of the issuance by the Commission of any stop order suspending the effectiveness of the Shelf Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Transfer
Restricted Securities for offering or sale in any jurisdiction, or the initiation of any proceeding for any of the preceding purposes, (D) except during a Blackout Period, of the existence of any fact or the happening of any event during the
Effectiveness Period that makes any statement of a material fact made in the Shelf Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein untrue, or that requires the making of
any additions to or changes in the Shelf Registration Statement or the Prospectus in order to make the statements therein not misleading, provided that the Company shall not be required to provide confidential information to Persons who have
not signed a confidentiality agreement. If at any time the Commission shall issue any stop order suspending the effectiveness of the Shelf Registration Statement, or any state securities commission or other regulatory authority shall issue an order
suspending the qualification or exemption from qualification of the Transfer Restricted Securities under state securities or blue sky laws, the Company shall use its reasonable best efforts to obtain the withdrawal or lifting of such order at the
earliest possible time; 

  
 6 

 (iv) make available at reasonable times for inspection, upon written
request, at the offices where normally kept, by one or more representatives of the Holders whose Transfer Restricted Securities are included in the Shelf Registration Statement, and one counsel retained by such selling Holders, all financial and
other records, pertinent corporate documents and properties of the Company and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such Holder, attorney or accountant in connection with
such Shelf Registration Statement or any post-effective amendment thereto subsequent to the filing thereof and prior to its effectiveness; provided, that if any such information is reasonably identified by the Company as being confidential or
proprietary, each Person receiving such information shall take such actions as are necessary to protect the confidentiality of such information, and shall sign confidentiality agreements requested by the Company prior to the receipt of such
information; 
 (v) if requested by any Holder whose Transfer Restricted Securities are included in the Shelf
Registration Statement, promptly incorporate in the Shelf Registration Statement or Prospectus, pursuant to a supplement or post-effective amendment if necessary, such information as such selling Holders may reasonably request to have included
therein, including, without limitation, information relating to the “Plan of Distribution” of the Transfer Restricted Securities; 
 (vi) furnish to each Holder whose Transfer Restricted Securities are included in the Shelf Registration Statement without charge, at least one copy of the Shelf Registration Statement, as first filed with
the Commission, and of each amendment thereto, including financial statements and schedules, all documents incorporated by reference therein and all exhibits (excluding exhibits incorporated therein by reference); 

(vii) deliver to each Holder whose Transfer Restricted Securities are included in the Shelf Registration Statement,
without charge, as many copies of the Prospectus (including each preliminary Prospectus) and any amendment or supplement thereto as such Persons reasonably may request; except during a Blackout Period or the existence of any fact or event of the
kind described in Section 5(b)(iii)(B) through (D), the Company hereby consents to the use of the Prospectus and any amendment or supplement thereto by each of the selling Holders in connection with the offering and the sale of such
Holder’s Transfer Restricted Securities covered by the Prospectus or any amendment or supplement thereto; 

(viii) prior to any public offering of Transfer Restricted Securities, cooperate with the Holders whose Transfer
Restricted Securities are included in the Shelf Registration Statement and the counsel for Committed Holders in connection with the registration and qualification of the Transfer Restricted Securities under the state securities or blue sky laws of
such jurisdictions as such Holders may reasonably request and do any and all other acts or things reasonably necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the Shelf
Registration Statement; provided, however, that the Company shall not be required to register or qualify as a foreign corporation where it is not then so qualified or to take any action that would subject it to the service of process
in suits or to taxation in any jurisdiction where it is not then so subject; 

  
 7 

 (ix) cooperate with the Holders whose Transfer Restricted Securities are
included in the Shelf Registration Statement to facilitate the timely preparation and delivery of certificates representing Transfer Restricted Securities to be sold and not bearing any restrictive legends; and enable such Transfer Restricted
Securities to be in such denominations and registered in such names as the Holders may reasonably request at least two Business Days prior to any sale of Transfer Restricted Securities made by such Holders; 

(x) use its reasonable best efforts to cause the Transfer Restricted Securities covered by the Shelf Registration
Statement to be registered with or approved by such other governmental agencies or authorities as may be reasonably necessary to enable the Holders whose Transfer Restricted Securities are included in the Shelf Registration Statement to consummate
the disposition of such Transfer Restricted Securities, subject to the proviso contained in Section 5(b)(viii) hereof, except as may be required solely as a consequence of the nature of such Holder’s (whose Transfer Restricted Securities
are included in the Shelf Registration Statement) business, in which case the Company will cooperate in all reasonable respects with the filing of such Shelf Registration Statement and the granting of such approvals; 

(xi) except during a Blackout Period, if any fact or event contemplated by Section 5(b)(iii)(D) hereof shall exist
or have occurred, promptly prepare a supplement or post-effective amendment to the Shelf Registration Statement or related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter
delivered to the purchasers of Transfer Restricted Securities, the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; 
 (xii) cause the Transfer Restricted Securities covered by the
Shelf Registration Statement to be listed or quoted, as the case may be, on each securities exchange or automated quotation system on which the Company’s common stock is then listed or quoted; and 

(xiii) during the Effectiveness Period, provide promptly to each Holder upon written request each document filed with the
Commission pursuant to the requirements of Section 13 and Section 15 of the Exchange Act after the effective date of the Shelf Registration Statement, unless such document is available through the Commission’s EDGAR and/or IDEA
system. 
 Each Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of any written notice from the
Company of the existence of any fact of the kind described in Section 5(b)(iii)(D) hereof or of a Blackout Period, such Holder will forthwith discontinue disposition of Transfer Restricted Securities pursuant to the applicable Shelf
Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus 

  
 8 

 
contemplated by Section 5(b)(xi) hereof, or until it is advised in writing (the “Advice”) by the Company that the use of the Prospectus may be resumed, and has received
copies of any additional or supplemental filings that are incorporated by reference in the Prospectus. If so directed by the Company, each Holder will deliver to the Company (at the Company’s expense) all copies, other than permanent file
copies then in such Holder’s possession, of the Prospectus covering such Transfer Restricted Securities that was current at the time of receipt of such notice. 
 In the event the Company shall give any such notice, the time period regarding the effectiveness of such Shelf Registration Statement set forth in Section 3 hereof shall be extended by the number of
days during the period from and including the date of the giving of such notice pursuant to Section 5(b)(iii)(D) hereof to and including the date when each selling Holder covered by such Shelf Registration Statement shall have received the
copies of the supplemented or amended Prospectus contemplated by Section 5(b)(xi) hereof or shall have received the Advice; provided, however, that no such extension shall be taken into account in determining whether Late Payments
are due pursuant to Section 4 hereof or the amount of such Late Payments, it being agreed that the Company’s option to suspend use of a Shelf Registration Statement pursuant to this paragraph shall be treated as a Registration Default for
purposes of Section 4 hereof, subject to the right to invoke Blackout Periods. 
 Each Holder agrees by acquisition of a
Transfer Restricted Security, that no Holder shall be entitled to sell any of such Transfer Restricted Securities pursuant to a Shelf Registration Statement, or to receive a Prospectus relating thereto, unless such Holder has furnished the Company
with a Notice and Questionnaire as required pursuant to Section 3(b) hereof (including the information required to be included in such Notice and Questionnaire) and the information set forth in the next sentence. The Company may require each
Notice Holder of Transfer Restricted Securities to be sold pursuant to the Shelf Registration Statement to furnish to the Company such information regarding the Holder and the distribution of such Transfer Restricted Securities as the Company may
from time to time reasonably require for inclusion in such Shelf Registration Statement. Each Notice Holder agrees promptly to furnish to the Company all information required to be disclosed in order to make the information previously furnished to
the Company by such Notice Holder not misleading and any other information regarding such Notice Holder and the distribution of such Transfer Restricted Securities as the Company may from time to time reasonably request in writing. The Company may
exclude from such Shelf Registration Statement the Securities of any Holder that fails to furnish such information within a reasonable time after receiving such request and such Securities shall no longer be entitled to the benefits hereunder.

 SECTION 6. Registration Expenses. 
 (a) All reasonable expenses incident to the Company’s performance of or compliance with this Agreement will be borne by the Company, regardless of whether a Shelf Registration Statement becomes
effective, including, without limitation: (i) all registration and filing fees and expenses; (ii) all fees and expenses of compliance with federal securities and state securities or blue sky laws; (iii) all expenses of printing
(including printing of Prospectuses and certificates for the Securities); and (iv) all fees and disbursements of counsel and accountants for the Company. 

  
 9 

 (b) The Company will reimburse the Holders of Transfer Restricted Securities being
registered pursuant to the Shelf Registration Statement, as applicable, for the reasonable fees and disbursements of Paul, Weiss, Rifkind, Wharton & Garrison LLP, counsel for the Committed Holders for whose benefit such Shelf Registration
Statement is being prepared. 
 SECTION 7. Indemnification. 

(a) The Company agrees to indemnify and hold harmless (i) each Holder, (ii) each Person, if any, who controls (within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) any Holder (any of the Persons referred to in this clause (ii) being hereinafter referred to as a “controlling person”) and (iii) the
respective officers, directors, partners, employees, representatives and agents of any or any controlling person (any Person referred to in clause (i), (ii) or (iii) may hereinafter be referred to as an “Indemnified
Holder”), to the fullest extent lawful, from and against any and all losses, claims, damages, liabilities, judgments, actions and expenses (including, without limitation, and as incurred, reimbursement of all reasonable out-of-pocket costs
of investigating, preparing, pursuing, settling, compromising, paying or defending any claim or action, or any investigation or proceeding by any governmental agency or body, commenced or threatened, including the reasonable fees and expenses of
counsel to any Indemnified Holder), joint or several, directly or indirectly caused by, related to, based upon, arising out of or in connection with any untrue statement or alleged untrue statement of a material fact contained in the Shelf
Registration Statement or Prospectus (or any amendment or supplement thereto) (or any preliminary prospectus or any Issuer Free Writing Prospectus or any amendment or supplement thereto), or any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages, liabilities or expenses are caused by an untrue statement or omission or alleged untrue statement
or omission that is based upon information relating to any of the Holders furnished in writing to the Company by or on behalf of the Holders expressly for use therein. This indemnity agreement shall be in addition to any liability which the Company
may otherwise have. 
 In case any action or proceeding (including any governmental or regulatory investigation or proceeding)
shall be brought or asserted against any of the Indemnified Holders with respect to which indemnity may be sought against the Company, such Indemnified Holder (or the Indemnified Holder controlled by such controlling person) shall promptly notify
the Company in writing; provided, however, that the failure to give such notice shall not relieve any of the Company of its obligations pursuant to this Agreement except to the extent that it had been materially prejudiced by such
failure and shall not, in any event, relieve the Company from any obligations to any Holder other than the indemnification obligation provided in the preceding paragraph. Such Indemnified Holder shall have the right to employ its own counsel in any
such action and the fees and expenses of such counsel shall be paid, as incurred, by the Company. The Company shall not, in connection with any one such action or proceeding or separate but substantially similar or related actions or proceedings in
the same jurisdiction arising out of the same general allegations or circumstances, be liable for the reasonable fees and expenses of more than one separate firm of attorneys (in addition to any local counsel) at any time for such Indemnified
Holders, which firm shall be designated by the Holders. The Company shall be liable for any settlement of any such action or proceeding effected with the Company’s prior written consent, which consent shall not be withheld unreasonably, and the
Company agrees to 

  
 10 

 
indemnify and hold harmless any Indemnified Holder from and against any loss, claim, damage, liability or reasonable out-of-pocket expense by reason of any settlement of any action effected with
the written consent of the Company. The Company shall not, without the prior written consent of each Indemnified Holder, settle or compromise or consent to the entry of judgment in or otherwise seek to terminate any pending or threatened action,
claim, litigation or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not any Indemnified Holder is a party thereto), unless such settlement, compromise, consent or termination (i) includes an
unconditional release of each Indemnified Holder from all liability arising out of such action, claim, litigation or proceeding and (ii) does not include a statement as to an admission of fault, culpability or a failure to act, by or on behalf
of the Indemnified Holder. 
 (b) By its acquisition of Transfer Restricted Securities each Holder of Transfer Restricted
Securities agrees, severally and not jointly, to indemnify and hold harmless the Company and its directors and officers who sign the Shelf Registration Statement, and any Person controlling (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) the Company and its officers, directors, partners, employees, representatives and agents, to the same extent as the foregoing indemnity from the Company to each of the Indemnified Holders, but only with
respect to claims and actions based on information relating to such Holder furnished in writing by such Holder expressly for use in any Shelf Registration Statement (or any amendment or supplement thereto) or Prospectus (or any amendments or
supplements thereto). In case any action or proceeding shall be brought against the Company or its directors or officers or any such controlling person in respect of which indemnity may be sought against a Holder of Transfer Restricted Securities,
such Holder shall have the rights and duties given the Company, and the Company, its directors and officers and such controlling person shall have the rights and duties given to each Holder by the preceding paragraph. 

(c) If the indemnification provided for in this Section 7 is unavailable to an indemnified party under Section 7(a) or
(b) hereof (other than by reason of exceptions provided in those Sections) in respect of any losses, claims, damages, liabilities, judgments, actions or expenses referred to therein, then each applicable indemnifying party, in lieu of
indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate to reflect the relative benefits
received by the Company, on the one hand, and the Holders, on the other hand, from the Initial Issuance (which in the case of the Company shall be deemed to be equal to the total gross proceeds to the Company from the Initial Issuance), plus the
amount of Late Payments which did not become payable as a result of the filing of the Shelf Registration Statement resulting in such losses, claims, damages, liabilities, judgments actions or expenses, or if such allocation is not permitted by
applicable law, the relative fault of the Company, on the one hand, and the Holders, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other
relevant equitable considerations. The relative fault of the Company, on the one hand, and of the Indemnified Holder, on the other hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Indemnified Holders, on the other hand, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed to include, subject to the
limitations set forth in the second paragraph of Section 7(a) hereof, any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or claim. 

  
 11 

 The Company and each Holder of Transfer Restricted Securities agree that it would not be
just and equitable if contribution pursuant to this Section 7(c) were determined by pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, liabilities or expenses referred to in the immediately preceding paragraph
shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions
of this Section 7, none of the Holders (and its related Indemnified Holders) shall be required to contribute, in the aggregate, any amount in excess of the amount by which the total market price of the Securities at the Closing Date exceeds the
amount of any damages which such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this Section 7(c) are several in
proportion to the respective principal amount of Securities held by each of the Holders hereunder and not joint. 

SECTION 8. Miscellaneous. 
 (a) Notwithstanding the fact that any Holder may have requested and the Company may have caused the removal of the restrictive legends relating to the Securities Act from the Securities, if the conditions
of Rule 144(c)(1) are still applicable to the Securities and those conditions have not been satisfied, each Holder acknowledges that it hereby will be prohibited from selling or otherwise transferring the Securities pursuant to Rule 144 until such
time as the conditions of Rule 144(c)(1) have been satisfied or a period of one year has elapsed since the later of the Closing Date or a date as of which the Securities were held by an Affiliate of the Company. The Company will provide the Holders
with prompt notice of (i) any circumstance that would cause the Securities to become so restricted and (ii) when the prohibition provided herein has elapsed and the Securities may be sold or transferred pursuant to Rule 144. 

(b) No Inconsistent Agreements. During the Effectiveness Period the Company will not on or after the date of this Agreement enter
into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise violates the provisions hereof. The rights granted to the Holders hereunder do not in any way conflict with
and are not inconsistent with the rights granted to the holders of the Company’s other issued and outstanding securities under any agreement in effect on the date hereof. 

  
 12 

 (c) Amendments and Waivers. The provisions of this Agreement may not be amended,
modified or supplemented, and waivers or consents to or departures from the provisions hereof may not be given, unless the Company has (i) in the case of Section 4 hereof and this Section 9(c)(i), obtained the written consent of
Holders of all outstanding Transfer Restricted Securities and (ii) in the case of all other provisions hereof, obtained the written consent of those Committed Holders who together hold a majority of the number of Transfer Restricted Securities
entitled to the benefits hereof held by all Committed Holders. 
 (d) Notices. All notices and other communications
provided for or permitted hereunder shall be made in writing by hand-delivery, first-class mail (registered or certified, return receipt requested), telex, telecopier, or air courier guaranteeing overnight delivery: 

(i) if to a Holder, at the address set forth on the records of the transfer agent of the Securities; and 

(ii) if to the Company: 
 GMX Resources Inc. 
 6400 North Broadway, Suite 600 

Oklahoma City, Oklahoma 73114 
 Telecopier No.: (405) 600-0600 
 Attention: James Merrill

 With a copy to: 
 Andrews Kurth LLP 
 600 Travis Street, Suite 4200 

Houston, Texas 77002 
 Telecopier No.: (713) 220-4385 
 Attention: David C. Buck,
Esq. 
 All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if
personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if telecopied; and on the next Business Day, if timely delivered to an air courier
guaranteeing overnight delivery. 
 (e) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties, including, without limitation, and without the need for an express assignment, subsequent Holders of Transfer Restricted Securities; provided, however, that this Agreement
shall not inure to the benefit of or be binding upon a successor or assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted Securities from such Holder. If any successor or assign of any Holder shall acquire
Transfer Restricted Securities, in any manner, whether by operation of law or otherwise, such Transfer Restricted Securities shall be held subject to all of the terms and conditions of this Agreement, and by taking and holding such Transfer
Restricted Securities, such Person shall be conclusively deemed to have agreed to be bound by and to perform all of the terms and conditions of this Agreement. 

  
 13 

 (f) Counterparts. This Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

(g) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the
meaning hereof. 
 (h) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICTS OF LAW RULES THEREOF. 
 (i) Severability. In the event that any
one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining
provisions contained herein shall not be affected or impaired thereby. 
 (j) Entire Agreement. This Agreement is
intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no
restrictions, promises, warranties or undertakings, other than those set forth or referred to herein with respect to the registration rights granted by the Company with respect to the Transfer Restricted Securities. This Agreement supersedes all
prior agreements and understandings between the parties with respect to such subject matter. 
 [Signature Page to Follow]

  
 14 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	GMX RESOURCES INC.
		
	By:	 	/s/ James A. Merrill
		 	 Name: James A. Merrill

Title: Chief Financial Officer

 [Signature Page to Registration Rights Agreement for Common Stock] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

									
	 CHATHAM ASSET MANAGEMENT, LLC,
 not in its individual capacity, but solely as investment advisor to the funds and accounts listed in Annex B-1
	 		 	 OMEGA ADVISORS, INC.,
 not in its individual capacity, but solely as investment advisor to the funds and accounts listed in Annex B-3

					
	By:	 	/s/ Kevin O’Malley	 		 	By:	 	/s/ Edward Levy
		 	Name: Kevin O’Malley	 		 		 	Name: Edward Levy
		 	Title: Member	 		 		 	Title: CFO

  

									
	 GSO CAPITAL PARTNERS LP,
 not in its individual capacity, but solely as investment advisor to the funds and accounts listed in Annex B-2
	 		 	 COOPERMAN FAMILY FUND FOR A
 JEWISH FUTURE, INC.

					
	By:	 	/s/ Marisa J. Beeney	 		 	By:	 	/s/ Leon Cooperman
		 	Name: Marisa J. Beeney	 		 		 	Name:
		 	Title: Authorized Signatory	 		 		 	Title:

 [Signature Page to Registration Rights Agreement for Common Stock] 

 Annex A 
 GMX RESOURCES, INC. 
 SELLING STOCKHOLDER NOTICE AND QUESTIONNAIRE

 GMX Resources, Inc. (“we,” “us” or the “Company”) intends to file a
shelf registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating to the resale of shares of the Company’s common stock held by the Committed
Holders who acquired shares pursuant to Commitment Agreements and Purchase Agreements (the “Committed Holders”). In order to comply with disclosure obligations established by the SEC, we must disclose certain information regarding each
stockholder whose common stock is to be registered for resale pursuant to the Registration Statement. In order to appropriately address these disclosure obligations, we are providing you with this Notice and Questionnaire. 

Please complete and return this Notice and Questionnaire by 9:00 a.m. (Houston time) on December 7, 2012.
Please email the completed Notice and Questionnaire to Chris Griffith (cgriffith@andrewskurth.com). 
 The undersigned
stockholder (the “Selling Stockholder”) of shares of common stock (the “Shares”) of the Company understand that the Company intends to file the Registration Statement with the SEC for the purpose of registering
under the Securities Act of 1933, as amended, the resale of the Shares held by the Selling Stockholder and other Committed Holders (the “Registrable Securities”). The Company suggests that you consult with legal counsel in
responding to this questionnaire. 
 The undersigned (for itself and not for any other Selling Stockholder) hereby provide the
following information to the Company and represents and warrants that such information is accurate and complete as of the date hereof: 
  

	1.	Names of Selling Stockholder: 

  

					
	 Full legal name of Selling Stockholder:
	 	 Full legal name of registered holder

(if different) through which the
 Registrable Securities owned by the
 Selling Stockholder are held:
	 	 
		 		 	
		 		 	

	2.	Ownership of Registrable Securities: 

  

			
	 Selling Stockholder:
	  	 Number of Registrable Securities owned:

		  	
		  	

  

			
	3.	  	Ownership of Other Securities of the Company:
		
		  	Except for the Shares listed in Item 2 above and in this Item 3 (which will be deemed to be marked “0” if left blank), the Selling Stockholder is not the
beneficial or registered owner of any other securities of the Company.
		
		  	Type and amount of other securities of the Company beneficially owned (as defined in Appendix 1) by the Selling Stockholder:
		
		  	  

		
		  	  

		
		  	State any exceptions here:
		
		  	  

		
		  	  

		
	4.	  	Relationship with U.S. Registered Broker-Dealers:
		
		  	(a) Is the Selling Stockholder a registered U.S. broker-dealer?
		
		  	            Yes             No
		
		  	(b) With respect to a Selling Stockholder that is not registered as U.S. broker-dealers, is such Selling Stockholder an affiliate of, or affiliated with, a registered U.S.
broker-dealer?
		
		  	For this purpose, an affiliate includes a person or entity that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, a U.S. registered broker-dealer.
		
		  	            Yes             No
		
		  	If “yes,” please identify the broker-dealer(s):
		
		  	  

  
 18 

			
		  	  

		
		  	(c) Answer the following two questions only if the answer to the previous question was “yes”:
		
		  	With respect to a Selling Stockholder that is affiliated with a registered U.S. broker-dealer, did such Selling Stockholder purchase the Registrable Securities in the ordinary
course of business?
		
		  	            Yes             No
		
		  	If “no,” please describe:
		
		  	  

		
		  	  

		
		  	If the answer to the foregoing question is “no,” such Selling Stockholder consents to being named as an underwriter in the Registration Statement with respect to any of
its Registrable Securities that are subsequently sold pursuant to the Registration Statement.
		
		  	With respect to a Selling Stockholder that is affiliated with a registered U.S. broker-dealer, at the time of purchase of the Registrable Securities, did such Selling Stockholder
have any agreements or understandings, directly or indirectly, with any person to distribute such Registrable Securities?
		
		  	            Yes             No
		
		  	If “yes,” please describe:
		
		  	  

		
		  	  

		
		  	If the answer to the foregoing question is “yes,” such Selling Stockholder consents to being named as an underwriter in the Registration Statement with respect to any
of its Registrable Securities that are subsequently sold pursuant to the Registration Statement.
		
	5.	  	Natural Persons Authorized to Act for Selling Stockholder:
		
		  	The SEC staff has indicated that it is staff policy to require that all selling stockholders named in a registration statement must disclose all natural persons (i.e.,
individuals) who exercise voting and/or dispositive power over the registered securities owned by the selling stockholder. This request must be completed by any Selling Stockholder that is not a natural person and by any Selling
Stockholder that is a natural person who has delegated voting or dispositive powers by contract or otherwise in respect of Registrable Securities. If the Selling Stockholder is a natural person that has not delegated such powers, please disregard
the request.

  
 19 

			
		
		  	Please list all natural persons who exercise voting or dispositive power with respect to any of the Registrable Securities owned by the Selling Stockholder and describe the
relationship by which they exercise such powers. If voting and dispositive powers are divided among such listed persons or among various classes of Registrable Securities, please so indicate. Attach a separate sheet if
necessary.

  
  

					
	 Selling Stockholder
	 	 Person(s) with Voting or

Dispositive
Power(1)
	 	 Relationship to Selling

Stockholder

and/or Registrable
 Securities

	  
	 	  
	 	  

	  
	 	  
	 	  

	  
	 	  
	 	  

	  
	 	  
	 	  

	  
	 	  
	 	  

	  
	 	  
	 	  

	  
	 	  
	 	  

  

	(1)	Please indicate whether such powers are divided among such persons or securities and, if so, the scope of the powers of each person. 

 

			
	6.	  	Relationships with the Company:
		
		  	Except as set forth below, neither the Selling Stockholder nor any of its affiliates has held any position or office or has had any other material relationship with the Company (or
its predecessors or affiliates) during the past three years.
		
		  	State any exceptions here:
		
		  	  

		
		  	  

		
		  	  

		
		  	In responding to this Item 6, please disclose the following relationships:
		
		  	 1.      whether any officer or director of the Selling Stockholder, or any affiliate of
the Selling Stockholder, is also a director of the Company; or

  
 20 

			
		  	 2.      any other position, office or material relationships within the meaning of Item 507
of Regulation S-K.

 In accordance with each of the
undersigned’s obligation under the Registration Rights Agreement to provide such information as may be required by law for inclusion in the Registration Statement, the undersigned agrees to promptly notify the Company of any inaccuracies or
changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective. 
 By signing below, the undersigned consent to the disclosure of the information contained in the answers to Items 1 through 6 and the inclusion of such information in the Registration Statement and the
related prospectus. The undersigned understand that such information will be relied upon by the Company in connection with the preparation and filing of amendments or supplements to the Registration Statement and the related prospectus. 

  
 21 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, have caused this Notice
and Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  

							
	Date: December     , 2012             	 		 	  

		 		 	[STOCKHOLDER NAME]
				
		 		 	By:	 	 
		 		 		 	Name:
		 		 		 	Title:

  
 PLEASE RETURN THE COMPLETED AND
EXECUTED NOTICE AND 
 QUESTIONNAIRE BY EMAIL BY 9:00 A.M. (HOUSTON TIME) ON DECEMBER 7, 

2012 TO: 

cgriffith@andrewskurth.com 
 AND 
 PLEASE RETURN THE ORIGINAL EXECUTED NOTICE AND QUESTIONNAIRE

 TO: 
 Chris Griffith 
 Andrews Kurth LLP 

600 Travis, Suite 4200 
 Houston, Texas 77002 

  
 22 

 Annex A 
 APPENDIX 1 
 A “beneficial owner” of a security includes any of the following
persons: 
 1 (1) any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or
otherwise, has: 
  

	 	(a)	voting power with respect to such security, which includes the power to vote, or to direct the voting of, such security; or 

 

	 	(b)	investment power with respect to such security, which includes the power to dispose, or to direct the disposition of, such security; 

2 (2) any person who, directly or indirectly, creates or uses a trust, proxy, power of attorney, pooling arrangement or any other
contract, arrangement or device with the purpose or effect of divesting such person of beneficial ownership of a security or preventing the vesting of such beneficial ownership as a part of a plan or scheme to evade the reporting requirements of
Section 13(d) or 13(g) of the United States Securities Exchange Act of 1934,as amended (the Exchange Act”); and 
  

	(3)	any person who has the right to acquire “Beneficial Ownership” (as defined by reference to paragraph (1) above) of a security within 60 days, including,
but not limited to, any right to acquire such security (a) through the exercise of any option, warrant or right, (b) through the conversion of a security, (c) pursuant to the power to revoke a trust, discretionary account or similar
arrangement, or (d) pursuant to the automatic termination of a trust, discretionary account or similar arrangement; provided, however, that any person who acquires a security or power specified in clauses (a), (b) or (c) above with
the purpose or effect of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having such purpose or effect, immediately upon such acquisition shall be deemed to be the Beneficial Owner of
the securities that may be acquired through the exercise or conversion of such security or power. 

 Annex B 
 Annex B-1 
 Chatham Asset High Yield Master Fund, Ltd. 

Chatham Eureka Fund, L.P. 
 Annex B-2

 GSO Special Situations Fund LP 

GSO Special Situations Overseas Master Fund Ltd. 

GSO Credit-A Partners LP 
 GSO Palmetto
Opportunistic Investment Partners LP 
 Annex B-3 
 Omega Capital Partners, LP 
 Omega Capital Investors, LP 

Omega Equity Investors, LP 
 Omega Overseas
Partners, Ltd. 
 Beta Equities, Inc. 

GS&Co. Profit Sharing Master Trust 
 Teachers
Retirement System of Texas 
 Omega Charitable Partnership, LPPurchase Agreement - GMX and Chatham Asset Management

 Exhibit 10.1 
 EXECUTION COPY 
 GMX RESOURCES INC. 

SENIOR SECURED NOTES SERIES B DUE 2017

 6,422,392 SHARES OF COMMON STOCK, PAR
VALUE $0.001 PER SHARE 
 PURCHASE AGREEMENT 

December 7, 2012 
 The
Purchaser named on the signature page hereto 
 Located at the address specified on the signature page hereto 

Ladies and Gentlemen: 
 GMX
Resources Inc., an Oklahoma corporation (the “Company”) proposes, upon the terms and conditions set forth in this agreement (this “Agreement”), to issue and sell to the purchaser named herein (the
“Purchaser”) on behalf of itself or on behalf of the funds and accounts listed on Annex 1 hereto for which Purchaser serves as investment advisor (the “Funds”), (i) the aggregate principal
amount of its Senior Secured Notes Series B due 2017 (the “Series B Notes”) that is indicated on the signature page of the Purchaser hereto and (ii) the aggregate number of shares of the Company’s common stock, par
value $0.001 per share (such purchased shares, the “Purchased Stock” and, collectively with the Series B Notes, the “Securities”), that is indicated on the signature page of the Purchaser hereto. The
purchase of the Securities hereunder is to be made as contemplated by a Commitment Agreement, dated as of November 7, 2012 (the “Commitment Agreement”) between the Company and the Purchaser. The Series B Notes
(i) are to be issued pursuant to an Indenture, dated as of December 19, 2011 (the “Existing Indenture”), as amended by the First Supplemental Indenture (“Supplemental Indenture No. 1”)
(the Existing Indenture, as so amended, the “Amended Indenture”), to be dated of even date herewith, in each case, entered into among the Company, the Guarantors (as defined below) party thereto and U.S. Bank National
Association, a national banking association, as trustee and collateral agent (in such capacity, the “Trustee”). The Company’s obligations under the Series B Notes, including the due and punctual payment of interest on
the Series B Notes, will be irrevocably and unconditionally guaranteed (the “Note Guarantees”) by the Restricted Subsidiaries of the Company who have agreed to be guarantors under the Amended Indenture (the
“Guarantors”), pursuant to a Notation of Guarantee, each to be dated of even date herewith, by the Guarantors (the “Notation of Guarantee”). As used herein, the term “Notes” shall include the
Note Guarantees, unless the context otherwise requires. This Agreement is to confirm the agreement concerning the purchase of the Series B Notes from the Company by the Purchaser and the Funds. The obligations of the Company and the Guarantors under
the Amended Indenture and the Series B Notes are also governed by a Security Agreement dated as of December 19, 2011 (the “Security Agreement”) between the Company and the U.S. Bank National Association, as Collateral
Agent (the “Collateral Agent”) and certain other security agreements and mortgages by and between the Company or the Guarantors, as applicable, and 

  

 
the Collateral Agent, of even date therewith (collectively, the “Security Documents”). The Securities will be subject to Registration Rights Agreements (the
“Registration Rights Agreements”) among the Company, the Guarantors and certain other purchasers of the Securities, of even date herewith. 
 A consent solicitation was commenced on November 16, 2012 pursuant to a consent solicitation statement in which the Company solicited consents from holders of the Company’s outstanding Senior
Secured Notes due 2017 (the “Existing Notes”) under the Existing Indenture. The purpose of the Consent Solicitation Statement (as defined below) was to obtain the consent of the holders of the Existing Notes to certain
proposed amendments to the Existing Indenture as set forth in Supplemental Indenture No. 1. 
 Collectively, the following
are referred to herein as the “Transaction Documents”: (i) this Agreement and the other purchase agreements dated as of the date hereof relating to the issuance and sale of the Securities pursuant to the Commitment
Agreement and the other commitment agreements (collectively, the “Securities Purchase Agreements” or the “SPAs”), (ii) the Amended Indenture, (iii) Supplemental Indenture No. 1,
(iv) the Series B Notes and the associated Note Guarantees, (v) the Registration Rights Agreements, (vi) the Security Documents and (vii) the Consent Solicitation Statement (including all documents incorporated by reference in
the Consent Solicitation Statement). Collectively, the transactions contemplated by the Transaction Documents (including, without limitation, the use of proceeds therefrom) are referred to herein as the “Transactions”.

 1. Purchase of the Securities. The Company and the Guarantors jointly and severally hereby agree, on the basis
of the representations, warranties, covenants and agreements of the Purchaser (for itself and on behalf of the Funds) contained herein and subject to all the terms and conditions set forth herein, to issue and sell to the Purchaser (for itself and
on behalf of the Funds) and, upon the basis of the representations, warranties and agreements of the Company and the Guarantors herein contained and subject to all the terms and conditions set forth herein, the Purchaser agrees, to purchase (for
itself and on behalf of the Funds) from the Company (a) the aggregate principal amount of Series B Notes that is indicated on the signature page hereto for a price in cash equal to 90.333% of the aggregate principal amount of such Series B
Notes, and (b) the aggregate number of shares the Purchased Stock that is indicated on the signature page hereto, for (i) a price per share equal to $0.48 in respect of an aggregate of 2,388,226 of such shares and (ii) a price per
share equal to $0.01 in respect of an aggregate of 4,034,166 of such shares.  
 2. Payment for and Delivery of
the Securities. Subject to the satisfaction or waiver of the conditions set forth in Section 6 below, the closing (the “Closing”) of the purchase and sale of the Securities shall occur on the date
hereof. The Closing will be held at the offices of Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York, or at such other location as the Company and the Purchaser may otherwise agree. The date hereof is referred to herein as
the “Closing Date.” 
 The Series B Notes will be delivered to the Purchaser, or
the Trustee as custodian for The Depository Trust Company (“DTC”), against payment by or on behalf of the Purchaser of the purchase price therefor by wire transfer in immediately available funds, by causing DTC to

  
 2 

 
credit the Series B Notes to the account of the Purchaser at DTC designated in Annex 2 hereto. The Series B Notes will be evidenced by one or more global securities in definitive form and
will be registered in the name of Cede & Co. as nominee of DTC. The Purchased Stock will be delivered to the Purchaser in certificated form against payment therefor. 
 3. Representations, Warranties and Agreements of the Company and the Guarantors. Each of the Company and the Guarantors, jointly and severally, represent, warrant and agree, on and as of the date
hereof, as follows: 
 (a) The Consent Solicitation Statement, dated November 16, 2012, as supplemented and
amended by Supplement No. 1 dated November 28, 2012 (together with the documents incorporated by reference therein, the “Consent Solicitation Statement”), together with the form of Supplemental Indenture No. 1
attached thereto, this Agreement and the form of Registration Rights Agreements attached hereto as Exhibit I, (collectively, the “Disclosure Package”), contains all the information specified in, and meeting the
requirements of, Rule 144A(d)(4) under the Securities Act of 1933 (the “Securities Act”). 
 (b) The Series B Notes and Note Guarantees are not of the same class (within the meaning of Rule 144A(d)(3) under the Securities Act) as securities of the Company or the Guarantors that are listed on a
national securities exchange registered under Section 6 of the Securities Exchange Act of 1934 (the “Exchange Act”) or that are quoted in a United States automated inter-dealer quotation system. 

(c) None of the Company or the Guarantors is, and after giving effect to the Transactions, none will be, an
“investment company” or a company “controlled” by an “investment company” within the meaning of the Investment Company Act and the rules and regulations of the Commission thereunder. 

(d) The offer and sale of the Securities pursuant hereto are exempt from the registration requirements of the Securities
Act. No form of general solicitation or general advertising within the meaning of Regulation D under the Securities Act (including, but not limited to, advertisements, articles, notices or other communications published in any newspaper, magazine or
similar medium or broadcast over television or radio, or any seminar or meeting whose attendees have been invited by any general solicitation or general advertising) was used by the Company or the Guarantors, any of their respective Affiliates or
any of their representatives in connection with the offer and sale of the Securities. 
 (e) No directed selling
efforts within the meaning of Rule 902 under the Securities Act were used by the Company, the Guarantors or any of their respective representatives with respect to the Securities sold outside the United States to non-U.S. persons, and the Company
and the Guarantors and any of their respective Affiliates and any person acting on their behalf has complied with and will implement the “offering restrictions” required by Rule 902 under the Securities Act. 

  
 3 

 (f) The Disclosure Package has been prepared by the Company and the
Guarantors for use in connection with the Consent Solicitation Statement and the issuance of the Securities pursuant to this Agreement. No other materials have been prepared by the Company or the other Guarantors for use in connection with the
issuance of the Securities. No order or decree preventing the use of the Disclosure Package, or any order asserting that the Transactions are subject to the registration requirements of the Securities Act has been issued, and no proceeding for that
purpose has commenced or is pending or, to the knowledge of the Company or the Guarantors, is contemplated. 

(g) As of the date hereof, the Disclosure Package does not contain an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. 
 (h) The statistical and market-related data included in or incorporated by reference into the Disclosure Package are based on or derived from sources that the Company and the Guarantors believe to be
reliable in all material respects. 
 (i) Each of the Company and the Guarantors and their respective
subsidiaries has been duly organized, is validly existing and in good standing as a corporation or limited liability company, as applicable, under the laws of its jurisdiction of organization and is duly qualified to do business and in good standing
as a corporation or limited liability company, as applicable, in each jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such qualification, except where the failure to be so qualified or in good
standing would not, in the aggregate, reasonably be expected to have (i) a material adverse effect on the condition (financial or otherwise), results of operations, stockholders’ equity, properties or business of the Company and the
Guarantors, taken as a whole or (ii) a material adverse effect on the performance by the Company and the Guarantors of this Agreement or any of the Transaction Documents (as defined below) or the consummation of any of the transactions
contemplated hereby or thereby (the events described in clauses (i) and (ii), collectively, a “Purchase Agreement Material Adverse Effect”); each of the Company, the Guarantors and their respective subsidiaries has all
power and authority necessary to own or hold its properties and to conduct the businesses in which it is engaged. The Company and the Guarantors do not own or control, directly or indirectly, any corporation, association or other entity other than
the subsidiaries listed on Exhibit II hereto. None of the subsidiaries of the Company or any of the Guarantors (other than as identified as such in Exhibit II) is a “significant subsidiary” (as defined in Rule 405 under the
Securities Act). 
 (j) The Company has the authorized and issued capitalization as set forth in the Disclosure
Package, and all of the issued and outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and non-assessable. 

(k) The equity interests of the Guarantors constitute all the issued and outstanding shares of all classes of the capital
stock of the Guarantors owned by the Company. All equity interests of the Guarantors are owned of record by the Company and have been duly and validly issued and are fully paid and nonassessable. 

  
 4 

 (l) The Existing Indenture has been duly and validly authorized by each of
the Company and the Guarantors and, as of the date immediately prior to the execution of Supplemental Indenture No. 1, constituted the valid and binding agreement of each of the Company and the Guarantors, enforceable against it in accordance
with its terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles
(regardless of whether such enforceability is considered in a proceeding in equity or at law). 
 (m)
Supplemental Indenture No. 1 has been duly and validly authorized by each of the Company and the Guarantors and constitutes the valid and binding agreement of each of the Company and the Guarantors, enforceable against it in accordance with its
terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles
(regardless of whether such enforceability is considered in a proceeding in equity or at law). 
 (n) The
Amended Indenture has been duly and validly authorized by each of the Company and the Guarantors and, as amended by Supplemental Indenture No. 1, constitutes the valid and binding agreement of each of the Company and the Guarantors, enforceable
against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by
general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law). Each of the Company and the Guarantors has all requisite corporate power and authority to execute, deliver and perform its
obligations under the Amended Indenture. No qualification of the Amended Indenture under the Trust Indenture Act of 1939 (the “Trust Indenture Act”) is required in connection with the offer and sale of the Series B Notes in
the manner contemplated hereby. 
 (o) The Company has all requisite corporate power and authority to execute,
issue, sell and perform its obligations under the Series B Notes. The Series B Notes have been duly authorized by the Company and, when duly executed by the Company in accordance with the terms of the Amended Indenture, assuming due authentication
of the Series B Notes by the Trustee, upon delivery to the Purchaser against payment therefor in accordance with the terms hereof, will be validly issued and delivered and will constitute valid and binding obligations of the Company entitled to the
benefits of the Amended Indenture, enforceable against the Company in accordance with their terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to
or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law). The Company has all requisite corporate power and authority to execute,
issue, sell the Purchased Stock. The Purchased Stock has been duly authorized by the Company and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued and fully paid and non-assessable. 

(p) Each of the Company and the Guarantors has all requisite corporate power and authority to execute, deliver and
perform its obligations under the Security Documents. Each Security Document has been duly and validly authorized by each of the Company and the Guarantors and constitutes the valid and binding agreement of each of the

  
 5 

 
Company and the Guarantors, enforceable against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization,
moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

(q) Each of the Company and the Guarantors has all requisite corporate power and authority to execute, deliver and
perform its obligations under the Registration Rights Agreements. The Registration Rights Agreements have been duly and validly authorized by each of the Company and the Guarantors and, upon its execution and delivery by all of the parties thereto,
will constitute the valid and binding agreement of each of the Company and the Guarantors, enforceable against it in accordance with its terms, except (i) as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency,
reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law) and (ii) as
any indemnification provisions contained therein relating to securities law liabilities may be unenforceable. 

(r) Each of the Guarantors has all requisite corporate power and authority to execute, issue, sell and perform its
obligations under the Note Guarantees and the related Notation of Guarantee. The Note Guarantees and Notations of Guarantee have been duly authorized by the Guarantors and, when duly executed by the Guarantors in accordance with the terms of the
Amended Indenture, will constitute valid and binding obligations of each of the Guarantors entitled to the benefits of the Amended Indenture, enforceable against each of the Guarantors in accordance with their terms, except as such enforceability
may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is
considered in a proceeding in equity or at law). 
 (s) Each of the Company and the Guarantors has all requisite
corporate power and authority to execute, deliver and perform its obligations under this Agreement and the other SPAs. Each such SPA has been duly and validly authorized by each of the Company and the Guarantors and, upon its execution and delivery
by each of the parties thereto, (assuming the due authorization, execution and delivery thereof by any other parties thereto other than the Company and the Guarantors) will constitute the valid and binding obligation of each of the Company and the
Guarantors, in accordance with the terms thereof, enforceable against it in accordance with its terms, except (i) as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and other
similar laws relating to or affecting creditors’ rights generally, by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law) and, as to rights of indemnification and
contribution with respect to liabilities under securities laws, by principles of public policy and (ii) as any indemnification provisions contained therein relating to securities law liabilities may be unenforceable. 

(t) To the extent described in the Disclosure Package, each Transaction Document conforms in all material respects to the
description thereof in the Disclosure Package. 

  
 6 

 (u) The Transactions will not (i) conflict with or result in a breach
or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company, the Guarantors or their respective subsidiaries, or constitute a default under, any indenture, mortgage, deed of
trust, loan agreement, license, lease or other agreement or instrument to which the Company, the Guarantors or any of their respective subsidiaries is a party or by which the Company, the Guarantors or any of their respective subsidiaries is bound
or to which any of the property or assets of the Company, the Guarantors or any of their respective subsidiaries is subject, except for Liens created by the Transaction Documents, (ii) result in any violation of the provisions of the
certificate of formation, limited liability company agreement, charter or by-laws (or similar organizational documents) of any of the Company, the Guarantors or any of their respective subsidiaries or (iii) result in any violation of any
statute or any judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction over any of the Company, the Guarantors or any of their respective subsidiaries or any of their properties or assets, except,
with respect to clauses (i) and (iii) above, where any such matters would not, individually or in the aggregate, have a Purchase Agreement Material Adverse Effect. 

(v) No consent, approval, authorization or order of, or filing, registration or qualification with any court or
governmental agency or body having jurisdiction over any of the Company, the Guarantors or any of their respective subsidiaries and properties or assets is required for the execution, delivery and performance by the Company and the Guarantors, to
the extent a party thereto, of the Transaction Documents or the completion of the Transactions, except (i) in connection with filings with the with the Commission on Form D pursuant to Regulation D under the Securities Act and Blue Sky filings
for the purpose of qualifying any or all of the Securities under the securities laws of any state or other jurisdiction, (ii) in connection with the registration process contemplated by the Registration Rights Agreements and/or
(iii) except where the failure to make or obtain any such filing, registration or qualification such matters would not, individually or in the aggregate, have a Purchase Agreement Material Adverse Effect. 

(w) Other than (i) as disclosed in the Disclosure Package and (ii) the Registration Rights Agreements, there
are no contracts, agreements or understandings between any of the Company and the Guarantors and any person, granting such person the right to require the Company or the Guarantors to file a registration statement under the Securities Act with
respect to any securities of the Company or the Guarantors owned or to be owned by such person. 
 (x) None of
the Company, the Guarantors nor any other person acting on behalf of the Company or the Guarantors has sold or issued any securities that would be integrated with the offering of any of the Securities contemplated by this Agreement pursuant to the
Securities Act, the rules and regulations thereunder or the interpretations thereof by the Commission. The Company and the Guarantors will take reasonable precautions designed to insure that any offer or sale, direct or indirect, in the United
States or to any U.S. person (as defined in Rule 902 under the Securities Act), of any Securities or any substantially similar security issued by the Company or the Guarantors, within six months subsequent to the date hereof, is made under
restrictions and other circumstances reasonably designed not to affect the status of the offer and sale of any of the Securities in the United States and to U.S. persons contemplated by this Agreement as transactions exempt from the registration
provisions of the Securities Act, including any sales pursuant to Rule 144A under, or Regulation S of, the Securities Act. 

  
 7 

 (y) Since the date of the latest audited financial statements included in or
incorporated by reference into the Disclosure Package and except as disclosed in the Disclosure Package, none of the Company, the Guarantors or any of their respective subsidiaries has (i) sustained any loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or court or governmental action, order or decree, (ii) issued or granted any securities, (iii) incurred any
liability or obligation, direct or contingent, other than liabilities and obligations that were incurred in the ordinary course of business, that is material to the Company and its subsidiaries, taken as a whole, (iv) entered into any
transaction not in the ordinary course of business, that is material to the Company and its subsidiaries, taken as a whole, (v) declared or paid any dividend on its capital stock, and (vi) since such date, there has not been any change in
the capital stock or limited liability interests, as applicable, or long-term debt of any of the Company, the Guarantors or any of their respective subsidiaries or any adverse change, or any development involving a prospective adverse change, in or
affecting the condition (financial or otherwise), results of operations, stockholders’ equity or limited liability company interests, as applicable, properties, management, business or prospects of any of the Company, the Guarantors or their
respective subsidiaries, in each case except as would not, in the aggregate, reasonably be expected to have a Purchase Agreement Material Adverse Effect and/or except, in the case of clauses (ii), (iii), (iv) and (vi), pursuant to the
Transactions. 
 (z) Except as disclosed in the Disclosure Package, there are no judicial, administrative, legal
or governmental proceedings (including any notice of violation or alleged violation) pending to which any of the Company, the Guarantors or any of their respective subsidiaries is a party or of which any property or assets of the Company, the
Guarantors or any of their respective subsidiaries is the subject that would, in the aggregate, reasonably be expected to have a Purchase Agreement Material Adverse Effect. To the Company’s and the Guarantors’ knowledge, no such
proceedings are threatened or contemplated by governmental authorities or others. 
 (aa) Except as would not
reasonably be expected to have a Purchase Agreement Material Adverse Effect: 
 (i) The facilities and properties owned, leased
or operated by the Company and the Guarantors or any of their subsidiaries (the “Properties”) do not contain any hazardous or toxic substances, materials or wastes defined or regulated as such in or under any Environmental
Law (as defined below), including, without limitation, asbestos, perchlorate, polychlorinated biphenyls and urea-formaldehyde insulation (“Materials of Environmental Concern”) in amounts or concentrations which
(i) constitute a violation of, or (ii) could reasonably be expected to give rise to liability on behalf of any of the Company or the Guarantors under, any and all applicable foreign, federal, state, local or municipal laws, rules, orders,
regulations, statutes, ordinances, codes, decrees, requirements of the government of the United States of America or any other nation, or of any political subdivision thereof, whether state or local (including common law) regulating, relating to or
imposing liability or standards of conduct concerning protection of (i) human health from exposure to any Materials of Environmental Concern or (ii) the environment, as now or may at any time be in effect during the term of this Agreement
(“Environmental Law”); 

  
 8 

 (ii) Materials of Environmental Concern have not been transported or disposed of from the
Properties, in violation of, or in a manner or to a location that could reasonably be expected to give rise to liability on behalf of the Company or the Guarantors under any Environmental Law, and no Materials of Environmental Concern have been
generated, treated, stored or disposed of at, on or under any of the Properties in violation of, or in a manner that could reasonably be expected to give rise to liability on behalf of the Company or the Guarantors under, any applicable
Environmental Law; and 
 (iii) there has been no release or threat of release of Materials of Environmental Concern at or from
the Properties or arising from or related to the operations of the Company or the Guarantors or any Subsidiary in connection with the Properties, or otherwise in connection with the Business, in violation of or in amounts or in a manner that could
reasonably be expected to give rise to liability on behalf of the Company or the Guarantors under Environmental Laws. 
 (bb) (i) Each “employee benefit plan” (within the meaning of Section 3(3) of the Employee Retirement Security Act of 1974, as amended (“ERISA”) and whether or
not subject to ERISA) that is or, in the past six years has been maintained, administered or contributed to, or has had any obligation to contribute to, by any of the Company, the Guarantors or any member of the respective Controlled Group (each a
“Plan”), has been maintained in all material respects in compliance with its terms and with the requirements of all applicable statutes, rules and regulations including ERISA and the Internal Revenue Code of 1986, as amended
(the “Code”); (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a
statutory or administrative exemption; (iii) no Plan is or was subject to Title IV of ERISA or is or was a Multiemployer Plan; (iv) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and
nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; and (v) none of the Company or the Guarantors or a member of a Controlled Group under any of them has any material liability with
regards to any post-retirement welfare benefit under a Plan other than as required by Part 6 of Subtitle B of Title I of ERISA or similar required continuation of coverage law. 

(cc) The Company, the Guarantors and their respective subsidiaries maintain insurance of the types and in the amounts
generally deemed adequate in all material respects for its business, including, but not limited to, directors’ and officers’ insurance, insurance covering real and personal property owned or leased by the Company, the Guarantors and their
respective subsidiaries against theft, damage, destruction, acts of vandalism and all other risks customarily insured against, all of which insurance is in full force and effect. None of the Company, the Guarantors or any of their respective
subsidiaries has been refused any insurance coverage sought or applied for, and the none of the Company, the Guarantors, or any such subsidiary has any reason to believe that it, the Guarantors and their respective subsidiaries will not be able to
renew their existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Purchase Agreement Material Adverse Effect.

  
 9 

 (dd) There is not currently and has not in the past been a failure on the
part of the Company, the Guarantors or their respective subsidiaries or, to the Company’s or the Guarantor’s knowledge, any of its respective directors or officers, in their capacities as such, to comply with any applicable provisions of
Sarbanes-Oxley and the rules and regulations promulgated in connection therewith, including Sections 302, 402 and 906, and the statements contained in any certification pursuant to Sarbanes-Oxley and related rules and regulations are complete and
correct. The Company and each Guarantor has established and maintains disclosure controls and procedures and internal control over financial reporting as are currently required (as such terms are defined in Rule 13a-15 and 15d-15 under the Exchange
Act); the Company’s and the Guarantor’s disclosure controls and procedures (A) are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is
accumulated and communicated to management, including the principal executive and principal financial officer of the Company, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure, and that
such information is recorded, processed, summarized and reported, within the time periods specified in the Exchange Act and the Rules and Regulations; (B) have been evaluated for effectiveness; and (C) are effective in all material
respects to perform the functions for which they were established. Except as discussed with the Company’s auditors and audit committee and as disclosed in the Disclosure Package, (A) there are no significant deficiencies or material
weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the Company’s or the Guarantor’s ability to record, process, summarize, and report financial data and
(B) there is, and there has been, no fraud, whether or not material, that involves management or other employees who have a role in the Company’s or the Guarantor’s internal control over financial reporting. Since the date of the end
of the last fiscal year for which audited financial statements are included or incorporated by reference in the Disclosure Package, there have been no significant changes in internal control over financial reporting or in other factors that could
significantly affect internal control over financial reporting, including any corrective actions with regard to significant deficiencies and material weaknesses. The Company has received no written comments from the staff of the Commission regarding
its periodic or current reports under the Exchange Act that remain unresolved and have not been disclosed in the Disclosure Package. 
 (ee) None of the Company or the Guarantors or any of their respective subsidiaries, nor, to the knowledge of the Company or the Guarantors, any director, officer, manager, member, agent, employee or other
person associated with or acting on behalf of the Company, the Guarantors or any of their respective subsidiaries, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to
political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act
of 1977; or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. 

(ff) None of the Transactions will violate or result in a violation of Regulations T, U and X of the Board of Governors
of the Federal Reserve System. 

  
 10 

 (gg) The Company, the Guarantors and their respective Affiliates have not
taken, directly or indirectly, any action designed to or that has constituted or that would reasonably be expected to cause or result in the stabilization or manipulation of the price of any of the Securities. 

(hh) Each of the Company, the Guarantors and their respective subsidiaries have (i) good and Defensible (as defined
below) title to all its interests in its producing natural gas and oil properties (including oil and gas wells, producing leasehold interests and appurtenant personal property) as described in the Disclosure Package as owned by it,
(ii) investigated title in accordance with customary industry procedures prior to acquiring any non-producing leasehold properties (including undeveloped locations or leases held by production, and those leases not held by production and
including exploration prospects) described in the Disclosure Package as owned by it, (iii) good and indefeasible title to its other real property as described in the Disclosure Package as owned by it and (iv) good title to its personal
property as described in the Disclosure Package as owned by it, in each case free and clear of all liens, claims, security interests, equities, or other encumbrances except those (a) described in the Disclosure Package or (b) that do not
materially interfere with the use or value of such properties taken as a whole as described in the Disclosure Package. All real property and buildings held under lease or license by the Company or its Subsidiaries are held under valid and subsisting
and enforceable leases or licenses with such exceptions as do not materially interfere with the use of such properties taken as a whole as they have been used in the past and are proposed to be used in the future as described in the Disclosure
Package. As used herein, “Defensible” means, with respect to title to the producing properties (including oil and gas wells and producing leasehold interests) described in the Disclosure Package as being owned by the Company,
the Guarantors or any of their respective subsidiaries, that the Company, the Guarantors and their respective subsidiaries (1) are entitled to receive not less than the net revenue interests of such properties as set forth in the reserve
reports of (x) MHA Petroleum Consultants, an independent petroleum engineering firm, relating to the Company’s estimated proved oil and natural gas reserves as of December 31, 2011 and (y) DeGolyer and MacNaughton, an independent
petroleum engineering firm, relating to the Company’s estimated proved oil and natural gas reserves as of December 31, 2011 (collectively, the “Reserve Reports”) of all hydrocarbons and minerals produced, saved and
marketed from such properties, and proceeds thereof, all without reduction, suspension or termination of such interests throughout the productive life of such properties, and (2) are obligated to bear a share of the costs and expenses relating
to the maintenance, exploration, drilling, completion, development, operation, plugging and abandonment of such properties greater than the working interests of such properties as set forth in the Reserve Reports, without increase throughout the
life of such properties. 
 (ii) Each of the Company, the Guarantors and their respective subsidiaries is in
possession of and is operating in compliance with all franchises, grants, authorizations, licenses, certificates, permits, easements, consents, orders and approvals (“Permits”) from all state, federal, foreign and other
regulatory authorities, and has satisfied the requirements imposed by regulatory bodies, administrative agencies or other governmental bodies, agencies or officials, that are required for the Company, the Guarantors and their respective subsidiaries
lawfully to own, lease and operate their properties and conduct their businesses as described in the Disclosure Package, and each of the Company, the Guarantors and their respective 

  
 11 

 
Subsidiaries is conducting its business in compliance with all of the laws, rules and regulations of each jurisdiction in which it conducts its business, in each case with such exceptions,
individually or in the aggregate, as would not have a Material Adverse Effect; each of the Company, the Guarantors and their respective subsidiaries has filed all notices, reports, documents or other information (“Notices”)
required to be filed under applicable laws, rules and regulations, in each case, with such exceptions, individually or in the aggregate, as would not have a Material Adverse Effect; and, except as otherwise specifically described in the Disclosure
Package, none of the Company, the Guarantors or any of their respective Subsidiaries has received any notification from any court or governmental body, authority or agency, relating to the revocation or modification of any such Permit or to the
effect that any additional authorization, approval, order, consent, license, certificate, permit, registration or qualification (“Approvals”) from such regulatory authority is needed to be obtained by any of them, in any case
where it is reasonably expected that obtaining such Approvals or the failure to obtain such Approvals, individually or in the aggregate, would have a Purchase Agreement Material Adverse Effect. 

(jj) Except as described in the Disclosure Package, the Company, the Guarantors and their respective subsidiaries own or
possess, or can acquire on reasonable terms, adequate patents, patent licenses, trademarks, service marks and trade names necessary to conduct the business now operated by them, and neither the Company, the Guarantors nor any of their respective
subsidiaries has received any notice of infringement of or conflict with asserted rights of others with respect to any patents, patent licenses, trademarks, service marks or trade names that, individually or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would have a Purchase Agreement Material Adverse Effect. 
 (kk) The
Security Documents have granted and created, in favor of the Trustee for the benefit of the holders of the Series B Notes as security for all of the Secured Obligations (as such term is defined in the Security Agreement), a valid and enforceable
Lien in the Collateral (as defined in the Amended Indenture), and such Liens are perfected Liens (subject to Permitted Liens as defined in the Amended Indenture). 

(ll) After giving effect to the Transactions, other than Liens granted pursuant to the Transaction Documents and
Permitted Liens, none of the Company or the Guarantors have pledged, assigned, sold or granted a security interest in the Collateral. After giving effect to the Transactions, no security agreement, financing statement, equivalent security or Lien
instrument or continuation statement authorized by the Company or any Guarantor and listing the Company or any Guarantor as debtor covering all or any part of the Collateral shall be on file or of record in any jurisdiction, except in respect of
Permitted Liens or such as may have been filed, recorded or made as contemplated by the Transaction Documents. 

(mm) The historical financial statements (including the related notes and supporting schedules) included in or
incorporated by reference into the Disclosure Package present fairly in all material respects the financial condition, results of operations and cash flows of the entities purported to be shown thereby, at the dates and for the periods indicated,
and have been prepared in conformity with accounting principles generally accepted in the United States applied on a consistent basis throughout the periods involved. 

  
 12 

 (nn) The Company, the Guarantors and their respective subsidiaries have
filed all necessary federal, state and material foreign income and material franchise tax returns required to be filed prior to the date hereof (taking into account extensions requested in good faith by the Company and in compliance with applicable
tax rules and regulations) and paid all taxes shown as due thereon; all such tax returns are complete and correct in all material respects; all material tax liabilities are adequately provided for on the books of the Company, the Guarantors and
their respective subsidiaries; and the Company and the Guarantors have no knowledge of any tax proceeding or action pending or threatened against the Company, the Guarantors or any of their respective subsidiaries that, individually or in the
aggregate, might have a Purchase Agreement Material Adverse Effect. 
 (oo) No labor disturbance by or dispute
with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company or such subsidiaries, is imminent that would reasonably be expected to have a Purchase Agreement Material Adverse Effect. 

(pp) The operations of the Company, the Guarantors and their respective subsidiaries are and have been conducted at all
times in compliance with applicable financial recordkeeping and reporting requirements of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism Act of 2001, the Currency and Foreign Transactions Reporting Act of 1970, as amended, and the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines,
issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company, the Guarantors or any of their respective subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or the Guarantors, threatened. 

(qq) None of the Company, the Guarantors or any of their respective subsidiaries nor, to the knowledge of any of the
Company or the Guarantors, any director, officer, manager, member, agent, employee or affiliate of any of the Company, the Guarantors or any of their respective subsidiaries is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company and the Guarantors will not directly or indirectly use the proceeds of the offering of the Securities, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. 

(rr) Immediately after the consummation of the Transactions, each of the Company and the Guarantors will be Solvent. As
used in this paragraph, the term “Solvent” means, with respect to a particular date, that on such date (i) the present fair market value (or present fair saleable value) of the assets of the relevant entity are not less
than the total amount required to pay the probable liabilities of such entity on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured, (ii) the relevant entity is able to realize upon
its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (iii) assuming 

  
 13 

 
the completion of the transactions contemplated by the Transaction Documents, the relevant entity is not incurring debts or liabilities beyond its ability to pay as such debts and liabilities
mature, (iv) the relevant entity is not engaged in any business or transaction, and is not about to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due consideration to the
prevailing practice in the industry in which such entity is engaged, and (v) the relevant entity is not a defendant in any civil action that is reasonably expected to result in a judgment that such entity is or would become unable to satisfy.
In computing the amount of such contingent liabilities at any time, it is intended that such liabilities will be computed at the amount that, in the light of all the facts and circumstances existing at such time, represents the amount that can
reasonably be expected to become an actual or matured liability. 
 (ss) To the best knowledge of the Company
and the Guarantors, no change in any laws or regulations is pending that could reasonably be expected to be adopted and if adopted, is reasonably expected to have, individually or in the aggregate with all such changes, a Purchase Agreement Material
Adverse Effect, except as set forth in or contemplated in the Disclosure Package. 
 (tt) The Company is subject
to Section 13 or 15(d) of the Exchange Act. 
 (uu) Except as set forth in the Disclosure Package, none of
the Company or the Guarantors is a party to any contract, agreement or understanding with any person that would give rise to a valid claim against any of them or the Purchaser for a brokerage commission, finder’s fee or like payment in
connection with the Transactions. 
 Any certificate signed by any officer of the Company and delivered to the Purchaser or
counsel for the Purchaser in connection with the offering of the Securities shall be deemed a representation and warranty by the Company, as to matters covered thereby, to the Purchaser, and not a representation or warranty by the individual
officer. 
 Any certificate signed by any officer of any of the Guarantors and delivered to the Purchaser or counsel for the
Purchaser in connection with the offering of the Securities shall be deemed a representation and warranty by such Guarantor, as to matters covered thereby, to the Purchaser, and not a representation or warranty by the individual officer. 

4. Representations, Warranties and Agreements of the Purchaser. The Purchaser (for itself and on behalf of the Funds) hereby
represents and warrants to the Company and the Guarantors as follows (it being understood that the Purchaser does not make any representation, warranty, covenant or agreement to any other purchaser of the Securities or to the Company or the
Guarantors on behalf of any other purchaser of the Securities): 
 (a) The Purchaser has full power and
authority to purchase the Securities issued and offered hereby. 
 (b) The Purchaser and each of the Funds
(i) is knowledgeable, sophisticated and experienced in making, and is qualified to make, decisions with respect to investments in securities representing an investment decision like that involved in the purchase of the Securities, and has
requested, received, reviewed and considered all information it deems 

  
 14 

 
relevant in making an informed decision to purchase the Securities; (ii) is acquiring the Securities in the ordinary course of its business and for its own account for investment purposes
only and with no present intention of distributing any of such Securities or any arrangement or understanding with any other persons regarding the distribution of such Securities; and (iii) will not, directly or indirectly, offer, sell, pledge,
transfer or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a pledge of) any of the Securities except in compliance with the Securities Act and any applicable state securities laws. 

(c) The Purchaser and each of the Funds is a “qualified institutional buyer” as defined in Rule 144A
and/or an institutional “accredited investor” as defined in Rule 501(a), in each case as promulgated under the Securities Act. 
 (d) The Purchaser understands and acknowledges (for itself and on behalf of the Funds) that (i) the Securities are being offered in transactions that rely on an exemption from registration provided
by Section 4(a)(2) under the Securities Act and an exemption from applicable state securities law requirements; (ii) the initial offering and issuance of the Securities has not been registered under the Securities Act or any other
securities laws; (iii) if in the future it decides to resell, pledge or otherwise transfer the Securities that it purchases hereunder, those Securities, absent an effective registration statement under the Securities Act, may be resold, pledged
or transferred only pursuant to an applicable exemption from registration under the Securities Act in accordance with any applicable securities laws of the states and other jurisdictions of the United States, and (iv) it will, and each
subsequent holder of any of the Securities that it purchases in this offering is required to, notify any subsequent purchaser of such Securities from it or subsequent holders, as applicable, of the resale restrictions referred to in clause
(iii) above. 
 (e) The Purchaser understands and acknowledges that (i) the Company and the Guarantors
are relying upon the truth and accuracy of the acknowledgements, representations, and agreements of the Purchaser set forth herein; (ii) none of the Company, the Guarantors, or any person acting on behalf of the foregoing has made any
statement, representation, or warranty, express or implied, to it with respect to the Company, the Guarantors, or the offer or sale of any Securities, other than the information included in the Disclosure Package. 

(f) The Purchaser understands that the Series B Notes will bear a restrictive legend substantially in the following form
or otherwise as required pursuant to the Amended Indenture: 
 “THIS NOTE HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN,
THE ACQUIRER 

  
 15 

 (1) REPRESENTS THAT 

(A) IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A “QUALIFIED INSTITUTIONAL BUYER” (WITHIN THE MEANING OF
RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, 
 (B) IT IS AN INSTITUTIONAL “ACCREDITED INVESTOR” (WITHIN THE MEANING OF RULE 501(a) (1), (2), (3) OR (7) UNDER THE SECURITIES ACT) (AN “INSTITUTIONAL ACCREDITED INVESTOR”),
OR 
 (C) IT IS NOT A UNITED STATES PERSON (WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT) AND

 (2) AGREES FOR THE BENEFIT OF THE ISSUER THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS
NOTE OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT IN ACCORDANCE WITH THE SECURITIES ACT AND ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES AND ONLY 

(A) TO GMX RESOURCES, INC. OR ANY OF ITS SUBSIDIARIES, 

(B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, 

(C) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, 

(D) IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, 

(E) IN A PRINCIPAL AMOUNT OF NOT LESS THAN $250,000, TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT, PRIOR TO SUCH
TRANSFER, DELIVERS TO THE TRUSTEE A DULY COMPLETED AND SIGNED CERTIFICATE (THE FORM OF WHICH MAY BE OBTAINED FROM THE TRUSTEE) RELATING TO THE RESTRICTIONS ON TRANSFER OF THIS NOTE, OR 

  
 16 

 (F) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER
THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH (2)(C) ABOVE OR (2)(D) ABOVE, A DULY COMPLETED
AND SIGNED CERTIFICATE (THE FORM OF WHICH MAY BE OBTAINED FROM THE TRUSTEE) MUST BE DELIVERED TO THE TRUSTEE. PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH (2)(E) OR (F) ABOVE, THE ISSUER RESERVES THE RIGHT TO REQUIRE THE
DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO
REPRESENTATION OR WARRANTY IS MADE AS TO THE AVAILABILITY OF ANY RULE 144 EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.” 
 (g) The Purchaser understands that the Purchased Stock will bear a restrictive legend substantially in the following form: 

“THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR AN APPLICABLE EXEMPTION TO THE REGISTRATION REQUIREMENTS
OF SUCH ACT OR SUCH LAWS. 
 THE ISSUER RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS,
CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE 

  
 17 

 
SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION OR WARRANTY IS MADE AS TO THE AVAILABILITY OF ANY RULE 144 EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT.” 
 (h)  (i) The Purchaser (for itself and on behalf of the Funds) has full right, power,
authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement, and (ii) the execution,
delivery and performance of the Agreement by the Purchaser and the consummation of the transactions herein contemplated will not violate any provision of the organizational documents of the Purchaser or any statute or any authorization, judgment,
decree, order, rule or regulation of any court or any regulatory body, administrative agency or other governmental body applicable to Purchaser or the Funds other than any Federal or State securities laws, as to which no representation is made by
the Purchaser. 
 (i) The Purchaser understands that no United States federal or state agency or any other
government or governmental agency has passed upon or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the
offering of the Securities. 
 (j) The Purchaser acknowledges (for itself and on behalf of the Funds) that the
Company, the Guarantors and its counsel will rely upon the accuracy of the foregoing acknowledgments, representations and agreements. The Purchaser agrees that if any of the acknowledgments, representations or agreements that Purchaser (for itself
and on behalf of the Funds) is deemed to have made by its purchase of the Securities is no longer accurate, it shall promptly notify the Company and the Guarantors. If the Purchaser is purchasing the Securities as a fiduciary or agent for one or
more investor accounts (including the Funds), the Purchaser represents that it has sole investment discretion with respect to each of those accounts. 
 (k) Neither the Purchaser nor any of the Funds who shall become a Beneficial Owner (as defined in the Rights Agreement, dated as of May 17, 2005, by and between the Company and UMB Bank, N.A., as
Rights Agent, as amended on the date hereof (the “Rights Agreement”) of the Shares on the Closing Date, is immediately prior to the Transactions, or will become as a result of and immediately after giving effect to the
Transactions, an Acquiring Person (as defined in the Rights Agreement) (i.e., a Beneficial Owner of 20% or more of the shares of Common Stock of the Company then outstanding). 
 5. Agreements of the Company and the Guarantors. The Company and the Guarantors, jointly and severally, agree with the Purchaser and the Funds as follows: 

(a) The Company and the Guarantors will apply the net proceeds from the sale of the Securities to be sold by the Company
hereunder in accordance with the description thereof set forth in the Disclosure Package. 

  
 18 

 (b) The Company, the Guarantors and their respective Affiliates will not
take, directly or indirectly, any action designed to or that has constituted or that reasonably could be expected to cause or result in the stabilization or manipulation of the price of any security of the Company and the Guarantors in connection
with the offering of the Securities. 
 (c) The Series B Notes will be eligible for clearance and settlement in
the United States through DTC and in Europe through Euroclear Bank, S.A./N.V., or Clearstream Banking, société anonyme. 
 (d) The Company and the Guarantors will not, and will not cause their respective Affiliates to, engage in any “directed selling efforts” within the meaning of Rule 902 under the Securities Act.

 (e) The Company and the Guarantors will, and will cause their respective Affiliates to, comply with and
implement the “offering restrictions” required by Rule 902 under the Securities Act with respect to the sale of the Securities 
 (f) The Company and the Guarantors agree not to sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Securities Act) that would be integrated
with the sale of the Securities in a manner that would require the registration under the Securities Act of the sale to the Purchaser of the Securities. The Company and the Guarantors will take reasonable precautions designed to insure that any
offer or sale, direct or indirect, in the United States or to any U.S. person (as defined in Rule 902 under the Securities Act) or U.S. resident (as defined in the Investment Company Act), of any Securities or any substantially similar security
issued by the Company or the Guarantors, within six months subsequent to the date on which the distribution of the Securities has been completed (as notified to the Company by the Purchaser), is made under restrictions and other circumstances
reasonably designed not to affect the status of the offer and sale of the Securities in the United States and to U.S. persons or U.S. residents contemplated by this Agreement as transactions exempt from the registration provisions of the Securities
Act, including any sales pursuant to Rule 144A under, or Regulations D or S of, the Securities Act. 
 (g) The
Company and the Guarantors agree to comply with all agreements set forth in the representation letters of the Company and the Guarantors to DTC relating to the approval of the Series B Notes by DTC for “book entry” transfer. 

6. Conditions to Purchaser’s Obligations. The obligations of the Purchaser and the Funds hereunder are subject (i) to
the accuracy of the representations and warranties of the Company and the Guarantors contained herein, (ii) to the accuracy of the statements of each of the Company, the Guarantors and each of their respective officers made in any certificate
delivered pursuant hereto, (iii) to the performance by the Company and the Guarantors of their respective obligations hereunder, and (iv) to each of the following additional terms and conditions: 

(a) All corporate proceedings and other legal matters incident to the authorization, form and validity of the Transaction
Documents and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the Purchaser, and the Company and the Guarantors shall have furnished
to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters. 

  
 19 

 (b) Andrews Kurth LLP, special counsel to the Company and the Guarantors,
and Crow & Dunlevy, special Oklahoma counsel to the Company and the Guarantors, shall have delivered such opinions as are reasonably satisfactory to counsel to the Purchaser and such other local counsel to the Company and the Guarantors, as
applicable, shall have delivered such other opinions as are reasonably satisfactory to counsel to the Purchaser; 
 (c) The Company shall have furnished or caused to be furnished to the Purchaser a certificate of the Chief Financial Officer of the Company, or other officers satisfactory to the Purchaser, dated the date
hereof, as to such matters as the Purchaser may reasonably request, including, without limitation, a statement that: 
 (i) The representations, warranties and agreements of the Company and the Guarantors, as applicable, in Section 3 herein and in any other Transaction Document to which each of the Company and any of
the Guarantors, as applicable, is a party are true and correct, and the Company and the Guarantors, as applicable, has complied with all its agreements contained herein and in any other Transaction Document to which it is a party and satisfied all
the conditions on its part to be performed or satisfied hereunder or thereunder; 
 (ii) They have carefully
examined the Disclosure Package and, in their opinion, the Disclosure Package, as of the date hereof, does not contain any untrue statement of a material fact and does not omit to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading. 
 (d) The Company shall have
furnished or caused to be furnished to the Purchaser a certificate of the Company, dated the date hereof, substantially in the form of Exhibit III hereto. 

(e) The Company shall have furnished or caused to be furnished to the Purchaser a solvency certificate, dated the date
hereof, substantially in the form of Exhibit IV hereto. 
 (f) The Series B Notes shall be eligible for
clearance and settlement through DTC. 
 (g) The Company, the Guarantors and the Trustee shall have executed and
delivered Supplemental Indenture No. 1, and the Purchaser shall have received an original copy thereof, duly executed by the Company and the Trustee. 
 (h) The Series B Notes shall have been duly executed and delivered by the Company and duly authenticated by the Trustee. The Purchased Stock shall have been duly and validly issued as contemplated hereby
and delivered to the Purchaser in certificated form. 

  
 20 

 (i) Each Notation of Guarantee shall have been duly executed and delivered
by the Guarantors. 
 (j) Each of the Transaction Documents shall have been duly executed and delivered by the
respective parties thereto (other than the Purchaser). 
 (k) The representations and warranties of each of the
Company and the Guarantors (to the extent a party thereto) contained in the Transaction Documents to which each of the Company and any such Guarantor is a party are true and correct as of the date hereof. 

(l) Series B Notes (in an aggregate principal amount equal to $30.0 million less the aggregate principal amount of Series
B Notes sold hereby) shall have been sold pursuant to the other SPAs simultaneously with the sale of the Series B Notes sold hereby, and an aggregate number of shares of the Company’s common stock, par value $0.001 per share (the
“Common Stock”), equal to 15,979,253 less the aggregate number of shares of Common Stock sold hereby shall have been sold pursuant to the other SPAs simultaneously with the sale of the Purchased Stock sold hereby, and the use
of proceeds therefrom shall conform to the description in the Disclosure Package. 
 (m) The Transactions shall
have been consummated as contemplated by the Disclosure Package. 
 (n) Prior to the Closing Date,
(a) trading in the Company’s Common Stock shall not have been suspended by the Commission or by the NYSE, (b) trading in securities generally on the NYSE shall not have been suspended or limited for two consecutive Business Days or
minimum or maximum prices shall not have been generally established on such exchange for two consecutive Business Days, or additional material governmental restrictions, not in force on the date of this Agreement, shall not have been imposed upon
trading in securities generally by such exchange or by order of the Commission or any court of other governmental authority for two consecutive Business Days and (c) a general banking moratorium shall not have been declared by either Federal or
New York State authorities and continue for two consecutive Business Days. 
 All opinions, letters, evidence and certificates
mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Purchaser. 

7. Indemnification and Contribution. 
 (a) Each of the Company and the Guarantors hereby agrees, jointly and severally, to indemnify and hold harmless the Purchaser, the Funds, their Affiliates, directors, officers and employees and each
person, if any, who controls the Purchaser or the Funds within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in
respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of the Securities), to which the Purchaser, the Funds, or such an affiliate, director, officer, employee or controlling
person may become subject, under the Securities Act or 

  
 21 

 
otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any breach by the Company or the Guarantors of any representation or warranty or
material failure to comply with any of the covenants and agreements contained in this Agreement, (ii) any untrue statement or alleged untrue statement of a material fact contained (A) in the Disclosure Package or in any amendment or
supplement thereto, (B) in any Blue Sky application or other document prepared or executed by the Company or the Guarantors (or based upon any written information furnished by the Company or the Guarantors) specifically for the purpose of
qualifying any or all of the Securities under the securities laws of any state or other jurisdiction (any such application, document or information being hereinafter called a “Blue Sky Application”), (iii) the omission
or alleged omission to state in the Disclosure Package, or in any amendment or supplement thereto, in any Blue Sky Application, any material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading or (iv) the Transactions (other than those contemplated by this Agreement) and shall reimburse the Purchaser, the Funds, and each such director, officer, employee or controlling person promptly upon demand for any
legal or other expenses reasonably incurred by the Purchaser, the Funds, or any such affiliate, director, officer, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim,
damage, liability or action as such expenses are incurred. The foregoing indemnity agreement is in addition to any liability that the Company and the Guarantors may otherwise have to the Purchaser, the Funds, or to any affiliate, director, officer,
employee or controlling person of the Purchaser or the Funds. 
 (b) Promptly after receipt by an indemnified
party under this Section 7 of notice of any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 7, notify the indemnifying
party in writing of the claim or the commencement of that action; provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability that it may have under this Section 7 except to the
extent it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure and; provided, further, that the failure to notify the indemnifying party shall not relieve it from any liability that
it may have to an indemnified party otherwise than under this Section 7. If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to
participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party. After notice from the indemnifying
party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 7 for any legal or other expenses subsequently incurred by the
indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that the Purchaser and the Funds shall have the right to employ counsel to represent jointly the Purchaser, the
Funds and their directors, officers, employees and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Purchaser or the Funds against any of the Company or the Guarantors
under this Section 7, if (i) the Company, the Guarantors, the Purchaser and the Funds shall have so mutually agreed; (ii) the Company and the Guarantors have failed within a reasonable time to retain counsel reasonably satisfactory to
the Purchaser and the Funds; (iii) any of the Purchaser, the Funds and their respective directors, managers, officers, employees and 

  
 22 

 
controlling persons shall have reasonably concluded, based on the advice of counsel, that there may be legal defenses available to them that are different from or in addition to those available
to the Company or the Guarantors; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Purchaser, the Funds or their directors, officers, employees or controlling persons, on the one hand, and the
Company or the Guarantors, on the other hand, and representation of both sets of parties by the same counsel would present a conflict due to actual or potential differing interests between them, and in any such event the fees and expenses of such
separate counsel shall be paid by the Company and the Guarantors. No indemnifying party shall (x) without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent
to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential
parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and does not include a statement as
to, or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, or (y) be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably
withheld), but if settled with the consent of the indemnifying party or if there be a final judgment of the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or
liability by reason of such settlement or judgment. 
 (c) If the indemnification provided for in this
Section 7 shall for any reason be unavailable to or insufficient to hold harmless an indemnified party under Section 7(a) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then each
indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, in such proportion as
shall be appropriate to reflect the relative fault of the Company and the Guarantors, on the one hand, and the Purchaser and the Funds, on the other, with respect to the statements or omissions that resulted in such loss, claim, damage or liability,
or action in respect thereof, as well as any other relevant equitable considerations. The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a
material fact relates to information supplied by the Company and the Guarantors, or the Purchaser and the Funds, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or
omission. The Company, the Guarantors, the Purchaser and the Funds agree that it would not be just and equitable if contributions pursuant to this Section 7(c) were to be determined by pro rata allocation or by any other method of allocation
that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this
Section 7 shall be deemed to include, for purposes of this Section 7 any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. 

  
 23 

 8. Notices, etc. All statements, requests, notices and agreements hereunder shall be
in writing, and: 
 (a) if to the Purchaser or the Funds, shall be delivered or sent by hand delivery, mail,
telex, overnight courier or facsimile transmission to the address specified on the signature page hereto, with a copy to Paul, Weiss, Rifkind, Wharton & Garrison LLP, 1285 Avenue of the Americas, New York, NY 10019, Attention: Lawrence Wee;
and 
 (b) if to any of the Company or the Guarantors, shall be delivered or sent by mail, overnight courier or
facsimile transmission to GMX Resources Inc., 9400 North Broadway, Suite 600, Oklahoma City, OK 73114, Attention: Chief Financial Officer, with a copy to Andrews Kurth LLP, 600 Travis Street, Suite 4200, Houston, TX 77002, Attention: David C. Buck,
Esq. 
 9. Survival. The respective indemnities, rights of contribution, representations, warranties and agreements of
the Company or the Guarantors and the Purchaser contained in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Securities and shall remain in full force and
effect, regardless of any termination of this Agreement or any investigation made by or on behalf of any of them or any person controlling any of them. 
 10. Definition of the Terms “Business Day”, “Affiliate”, and “Subsidiary.” For purposes of this Agreement, (a) “business day” means any day on which the
New York Stock Exchange, Inc. is open for trading, and (b) “affiliate” and “subsidiary” have the meanings set forth in Rule 405 under the Securities Act. 

11. Governing Law. This Agreement and any matters arising out of or in any way relating to this Agreement shall be governed by
and construed in accordance with the laws of the State of New York. 
 12. Submission to Jurisdiction. Each of the
parties hereto hereby irrevocably and unconditionally: 
 (a) submits for itself and its property in any legal action or
proceeding relating to this Agreement or any of the transactions contemplated hereby, or for recognition and enforcement of any judgment in respect thereof, to the non-exclusive general jurisdiction of the State or Federal courts sitting in the
Borough of Manhattan, the City of New York (“New York Courts”); 
 (b) consents that any such action or
proceeding may be brought in such New York Courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such New York Court or that such action or proceeding was brought in an inconvenient
court and agrees not to plead or claim the same; 
 (c) agrees that service of process in any such action or proceeding may be
effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to any party hereto at its address set forth in Section 9 or at such other address of which such party shall have
been notified pursuant thereto; and 

  
 24 

 (d) agrees that nothing herein shall affect the right to effect service of process in any
other manner permitted by law or shall limit the right to sue in any other jurisdiction; and waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this
Section 13 any special, exemplary, punitive or consequential damages. 
 13. Waiver of Jury Trial. The Company, the
Guarantors and the Purchaser hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. 
 14. Counterparts. This Agreement may be executed in one or more counterparts and, if executed in more than one
counterpart, the executed counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. 
 15. Headings. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. 

16. Delivery of Payment. If the Company has not received payment in full for any of the Securities purchased pursuant hereto prior
to 4:00 p.m., New York City time, on December 7, 2012, upon written request by the Company, the Purchaser shall surrender to the Company for cancellation such Securities for which payment has not been received. 

17. Purchase Price Allocation. The parties hereto acknowledge that the “issue price,” within the meaning of
Section 1273(b) of the Code, of each Series B Note shall be $903.333 per $1,000 of principal amount of each Series B Note and the “yield to maturity,” based on such issue price, of each Series B Note is 13.741%, assuming all interest
on each Series B Note is paid entirely in cash. Except as otherwise required by law, the parties hereto agree that such issue price and yield to maturity shall be used to determine the amount of “original issue discount” accruing and to be
reported on the Series B Notes pursuant to Section 1272 of the Code and the regulations promulgated thereunder. 
 18.
Restricted Period. 
 (a) Except as noted in clause (b) below, the Purchaser and each Fund agrees
that during the 30-day period following the Closing Date (the “Restricted Period”), with respect to all of the Purchased Stock acquired under this Agreement and beneficially owned by such Purchaser or any Fund, it will not
(i) loan, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, such
Purchased Stock or any security convertible into or exchangeable for such Purchased Stock, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such
Purchased Stock, whether any such transaction described in clause (i) or (ii) above is settled by delivery of such Purchased Stock or other securities, in cash or otherwise (any disposition or arrangement described in clause (i) or
(ii) above being referred to herein as a “Disposition”), or publicly disclose any intent to make any Disposition, without, in each case, the prior written consent of the Company. 

  
 25 

 (b) Notwithstanding the provisions of clause (a) of this Section,
during the Restricted Period, the Purchaser or any Fund may (a) sell, transfer or otherwise dispose of such Purchased Stock in a private transaction, without the prior written consent of the Company, to any affiliate of the Purchaser or any
Fund managed by the Purchaser that agrees in writing with the Company to be bound by the terms of this Agreement, (b) pledge the Purchased Stock and as security for bona fide loans, letters of credit, interest rate or other hedging transactions
and related fees, costs, indemnities and other obligations from one or more third parties who are not affiliates of such parties, (c) sell all or a portion of such shares of Purchased Stock, as a result of any divestiture ordered by, or agreed
to with, a governmental authority. In addition, clause (a) of this Section shall also not restrict or affect the manner of sale or other disposition of any Purchased Stock in connection with any foreclosure or other disposition after default of
a lender or other counterparty in connection with the pledge of such securities for bona fide loans, letters of credit, interest rate or other hedging transactions and related fees, costs, indemnities and other obligations from one or more third
parties who are not affiliates of such party and shall not apply to any permitted transferee who does not assume the rights and obligations of such Purchaser or Fund in accordance with the Registration Rights Agreement relating to the resale of the
Purchased Stock. 

  
 26 

 EXECUTION COPY 

If the foregoing correctly sets forth the agreement among the Company, the Guarantors and the Purchaser, please indicate your acceptance
in the space provided for that purpose below. 
  

			
	GMX RESOURCES INC.
		
	By:	 	/s/ James A. Merrill
		 	Name: James A. Merrill
		 	Title: Chief Financial Officer

  

			
	 The Company hereby acknowledges receipt of $12,079,081.83 from the Purchaser as payment for the Securities indicated on the
signature page hereto.
  
 GUARANTORS:

 
 ENDEAVOR PIPELINE INC.
 DIAMOND BLUE DRILLING CO.

		
	By:	 	/s/ James A. Merrill
		 	Name: James A. Merrill
		 	Title: Vice President

  

 Accepted: 
 Chatham Asset Management, LLC, 
 not in its individual capacity, but solely as investment advisor
to the funds and accounts listed on Annex 1 hereto 
  

			
		
	By:	 	/s/ Kevin O’Malley
		 	 Name: Kevin O’Malley

Title: Member

 The above Purchaser hereby acknowledges receipt of $12,058,000 aggregate principal amount of Series B Notes and 6,422,392
aggregate number of shares of Purchased Stock. 
 By executing and delivering this Agreement, Purchaser represents that it is (at least one box
must be checked): 
 x a “qualified institutional buyer” as defined in
Rule 144A under the Securities Act; and/or 
  ̈ an “accredited
investor” as defined in Rule 501(a) under the Securities Act. 
 By executing and delivering this Agreement, Purchaser represents
that Chatham Asset High Yield Master Fund, Ltd., as listed on Annex 1 hereto, is (at least one box must be checked): 
 x a “qualified institutional buyer” as defined in Rule 144A under the Securities Act; and/or 
  ̈ an “accredited investor” as defined in Rule 501(a) under the Securities Act. 
 By executing and delivering this Agreement, Purchaser represents that Chatham Eureka Fund, L.P., as listed on Annex 1 hereto, is (at least one box must be checked): 

x a “qualified institutional buyer” as defined in Rule 144A under the
Securities Act; and/or 
  ̈ an “accredited investor” as defined in
Rule 501(a) under the Securities Act.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]